A Prospective, non-randomized, multi-center, clinical trial to evaluate the safety and efficacy of the Absolute Pro Peripheral self-expanding stent system in subjects with atherosclerotic de novo or restenotic lesions in the the native common iliac artery and/or native external iliac artery. (MOBILITY)

ID Number 09-2311

Principal Investigator(s)
Prakash Krishnan

Department(s) or Division(s)

Research Entity
The Zena and Michael A. Wiener Cardiovascular Institute

Peripheral artery disease (PAD) affects approximately 8 million Americans, and is associated with significant morbidity and mortality. PAD affects the lower extremities and is common in an aging population. It is estimated that only about 25 percent of patients undergo treatment for the disease and is associated with a significant reduction in a patient’s health-related quality of life. The purpose of this study is to find out whether the Absolute Pro Peripheral Self-Expanding Stent system is safe and effective when used to treat a narrowing in the iliac artery, an artery located in the legs. ClinicalTrials.gov Identifier: NCT00844532

Contact Information
Mary Kathryn Holten
(212) 241-4698

Recruiting Patients: Yes